Clinical trials: Inspiratory Resistance
- Condition Inspiratory Resistance
- Funder type Industry (pharma, biotech, devices)
- Accepts healthy volunteers yes
Pulmonary Disease, Chronic Obstructive
Breathing With a Facemask Exercise Performance
This study will determine the dyspnea response in chronic lung disease volunteers during treadmill walking with and without added inspiratory resistance.
- Trial name
- NCT05633017
- Testing
- CereVu Objective Dyspnea Score
- Where
- United States
- Volunteers
- 52 people, healthy volunteers welcome
- Sponsor
- CereVu Medical, Inc.
Stress, Diaphragmatic Breathing
Scalable Intervention for Stress Management
The purpose of this research is to measure the acceptance of a resistance breathing intervention and to assess whether it produces physiological and subjective effects in a laboratory setting.
- Trial name
- NCT07127575
- Testing
- Resistance Breathing Device, Electronic Resistance Breathing Device
- Where
- United States
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Livotion, LLC
Stress, Breathing Exercise
Real World Assessment of Resistance Breathing Device
The purpose of this study is to examine the usability and effectiveness of a stress management device during an academic exam period and asks the following questions: To what extent is a resistance breathing device (AIRpen)…
- Conditions
- Stress, Breathing Exercise, Stress Management
- Trial name
- NCT07187349
- Where
- United States
- Volunteers
- 73 people, healthy volunteers welcome
- Sponsor
- Livotion, LLC
Healthy Subjects
A Trial to Determine How Long Insulin and FDKP (the Molecule That Forms Technosphere Particles) Stays in the Lungs of Healthy Individuals After Inhalation of Technosphere® Insulin (TI) Powder Using Bronchoalveolar Lavage (BAL)
Lavage fluid (BAL) is inserted into a lung lobe using a flexible bronchoscope. The fluid is aspirated out to remove any remaining TI. It's performed twice at specific time points in 12 healthy volunteers.
- Trial name
- NCT00757367
- Testing
- TI Inhalation Powder
- Where
- United States
- Volunteers
- 13 people, healthy volunteers welcome
- Sponsor
- Mannkind Corporation
Lung Diseases, Pulmonary Disease
A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis
Although Cystic Fibrosis is a complex genetic disease affecting many organs, lung disease is the primary cause of mortality. The objective of this study is to determine the safety and tolerability of SNSP113 in healthy subjects…
- Conditions
- Lung Diseases, Pulmonary Disease, Cystic Fibrosis, Cystic Fibrosis Lung
- Trial name
- NCT03309358
- Testing
- Inhaled SNSP113
- Where
- 2 sites in United Kingdom
- Volunteers
- 32 people, healthy volunteers welcome
- Sponsor
- Synspira, Inc.